Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial-Reference-Cited by-同舟云学术

Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

Published:2009-05-23 Issue:3 Volume:3 Page:445-452
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Shindo Michiko,Chayama Kazuaki,Mochida Satoshi,Toyota Joji,Tomita Eiichi,Kumada Hiromitsu,Yokosuka Osamu,Sata Michio,Hayashi Norio,Suzuki Kazuyuki,Okanoue Takeshi,Tsubouchi Hirohito,Ishikawa Hiroki,Seriu Taku,Omata Masao

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-009-9135-0.pdf

Reference23 articles.

1. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000;61:362–366. doi: 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I

2. Kao JH, Chen DS. The natural history of hepatitis B virus infection. In Lai CL, Locarnini S, editors. Hepatitis B Virus. London: International Medical Press; 2002. 161–172

3. Lok AS, McMahon BJ. American Association for the Study of Liver Diseases (AASLD) practice guidelines. Chronic Hepatitis B. Hepatology 2007;45:507–539. doi: 10.1002/hep.21513

4. Rivkin A. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin 2005;21:1845–1856. doi: 10.1185/030079905X65268

5. Wong DKH, Cheung AM, O’Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312–323

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial;Clinical Infectious Diseases;2021-09-06

2. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis;Expert Review of Anti-infective Therapy;2020-05-12

3. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review;Journal of Gastroenterology;2020-03-17

4. From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature;SSRN Electronic Journal;2020

5. Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses Via Hypothesized Alleviation of CD147-Mediated Vascular Occlusion;SSRN Electronic Journal;2020